1[1]Teede HJ,Hutchison S,Zoungas S,et al.Insulin resistance,the metabolic syndrome,and cardiovascular disease risk in women with PCOS.Endocrine,2006,30:45-53.
2[2]Baron AD.Insulin resistance and vascular function.J Diabetes Complications,2002,16:92-102.
3[3]Chen MJ,Yang WS,Yang Jl-I,et al.Relationship betweenandrogen levels and blood pressure in young women with potycystic ovary syndrome.Hypertension,2007,49:1442-1447.
4[4]de la Calle M,Gallardo T,Diestro MD.Increased homocysteine levels in polycystic ovary syndrome.Med Clin (Barc),2007,129:292-294.
6[6]Benson S,Janssen OE,Hahn S,et al.Obesity,depression,and chronic low-grade inflammation in women with polycystic ovary syndrome.Brain Behav Immun,2008,22:177-184.
7[7]Legro RS,Kunselman AR,Dodson WC,et al.Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome:a prospective,controlled study in 254 affected women.J Clin Endocrinol Metab,1999,84:165-169.
8[8]Daviglus ML,Stamler J,Pirzada A,et al.Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality.JAMA,2004,292:1588-1592.
9[9]Orio FJ,Palomba S,Spinelli L,et al.The cardiovascular risk of young women with polycystic ovary syndrome:an observational,analytical,prospective case-control study.J Clin Endocrinol Metab,2004,89:3696-3701.
10[10]Meyer C,MeGrath BP,Cameron J,et al.Vascular dysfunction and metabolic parameters in polycystic ovary syndrome.J Clin Endocrinol Metab,2005,90:4630-4635.
